CN103191460B - Chitosan-silicone dressing as well as preparation method and application thereof - Google Patents
Chitosan-silicone dressing as well as preparation method and application thereof Download PDFInfo
- Publication number
- CN103191460B CN103191460B CN201310128403.XA CN201310128403A CN103191460B CN 103191460 B CN103191460 B CN 103191460B CN 201310128403 A CN201310128403 A CN 201310128403A CN 103191460 B CN103191460 B CN 103191460B
- Authority
- CN
- China
- Prior art keywords
- silicone
- chitosan
- dressing
- parts
- trauma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
技术领域 technical field
本发明涉及一种医用敷料及其制备方法和用途。 The invention relates to a medical dressing and its preparation method and application.
背景技术 Background technique
临床上,为了抑制烧伤、外伤、手术、感染等原因引起的各种增生性疤痕及保护烧伤、外伤、手术、感染等原因引起的各种创面,控制创面感染,保持创面湿润,促进创面愈合,往往采用各种不同的治疗手段和产品,但现有的方法和产品在治疗效果上往往不尽人意。 Clinically, in order to inhibit various hypertrophic scars caused by burns, trauma, surgery, infection, etc. and protect various wounds caused by burns, trauma, surgery, infection, etc., control wound infection, keep the wound moist, and promote wound healing. Various treatment methods and products are often used, but the existing methods and products are often unsatisfactory in therapeutic effect.
发明内容 Contents of the invention
本发明的目的在于提供一种配方合理,制备方便,治疗效果好的壳聚糖硅酮敷料及其制备方法和用途。 The object of the present invention is to provide a chitosan silicone dressing with reasonable formula, convenient preparation and good therapeutic effect, as well as its preparation method and application.
本发明的技术解决方案是: Technical solution of the present invention is:
一种壳聚糖硅酮敷料,其特征是:由下列重量百分比的成分组成: A kind of chitosan silicone dressing is characterized in that: it is made up of the composition of following percentage by weight:
壳聚糖 0.1%~5% Chitosan 0.1%~5%
硅酮 1~50% Silicone 1~50%
有机硅抗菌剂 0.5~5% Silicone antibacterial agent 0.5~5%
基质 余量。 Substrate margin.
所述硅酮的分子量为200~10000,为甲基硅油、乙基硅油、苯基硅油、甲基含氢硅油或甲基苯基硅油。 The molecular weight of the silicone is 200-10000, which is methyl silicone oil, ethyl silicone oil, phenyl silicone oil, methyl hydrogen silicone oil or methyl phenyl silicone oil.
所述有机硅抗菌剂是有机硅胍盐、有机硅季铵盐或氟硅唑。 The organosilicon antibacterial agent is organosilicon guanidine salt, organosilicon quaternary ammonium salt or flusilazole.
所述敷料的剂型为气雾剂,其基质由乙醚或石油醚与氟利昂或134a组成。 The dosage form of the dressing is an aerosol, and its matrix is composed of ether or petroleum ether and Freon or 134a.
所述敷料的剂型为凝胶剂,其基质成分为聚乙烯醇、羟乙基纤维素、羟甲基纤维素中的2~3个成分混合而成。 The dosage form of the dressing is a gel, and its matrix component is a mixture of 2-3 components of polyvinyl alcohol, hydroxyethyl cellulose and hydroxymethyl cellulose.
所述敷料的剂型为霜剂,其基质成分由下列重量份的成分组成: The dosage form of the dressing is a cream, and its base component is composed of the following components by weight:
单硬脂酸甘油酯 30~60份 Glyceryl monostearate 30~60 parts
硬脂酸 80~120份 Stearic acid 80~120 parts
白凡士林 40~60份 White Vaseline 40~60 parts
液体石蜡 130~180份 Liquid paraffin 130~180 parts
甘油 80~120份 Glycerin 80~120 parts
吐温-80 120~150份 Tween-80 120~150 parts
纯化水 350~550份。 Purified water 350~550 parts.
一种壳聚糖硅酮敷料的制备方法,其特征是:将壳聚糖、硅酮与有机抗菌剂混合,溶于基质中,然后灌装于包装容器中,辐照消毒后,得产品。 The preparation method of a chitosan silicone dressing is characterized in that the chitosan, silicone and organic antibacterial agent are mixed, dissolved in a substrate, filled in a packaging container, and irradiated to obtain a product.
一种壳聚糖硅酮敷料在制备抑制烧伤、外伤、手术、感染引起的增生性疤痕及保护烧伤、外伤、手术、感染引起的各种创面的制品中的应用。 Application of a chitosan silicone dressing in the preparation of products for inhibiting hypertrophic scars caused by burns, trauma, surgery and infection and protecting various wounds caused by burns, trauma, surgery and infection.
本发明配方合理,制备方便,可以有效抑制烧伤、外伤、手术、感染等原因引起的各种增生性疤痕及保护烧伤、外伤、手术、感染等原因引起的各种创面,控制创面感染,保持创面湿润,促进创面愈合;经100多例临床病例验证,有效率达95%以上;产品对金黄色葡萄球菌、大肠杆菌抑菌能力达到≥99%。 The invention has reasonable formula and convenient preparation, can effectively inhibit various hypertrophic scars caused by burns, trauma, surgery, infection, etc., protect various wounds caused by burns, trauma, surgery, infection, etc., control wound infection, and maintain wound surface Moisturizes and promotes wound healing; verified by more than 100 clinical cases, the effective rate is over 95%; the antibacterial ability of the product against Staphylococcus aureus and Escherichia coli reaches ≥99%.
下面结合实施例对本发明作进一步说明。 The present invention will be further described below in conjunction with embodiment.
具体实施方式 Detailed ways
实施例1: Example 1:
一种壳聚糖硅酮敷料,由下列重量百分比的成分组成: A chitosan silicone dressing consists of the following ingredients in percentage by weight:
壳聚糖 0.1%~5%(例0.1%、3%、5%) Chitosan 0.1%~5% (eg 0.1%, 3%, 5%)
硅酮 1~50%(例1%、25%、50%) Silicone 1~50% (eg 1%, 25%, 50%)
有机硅抗菌剂 0.5~5%(例0.5%、3%、5%) Silicone antibacterial agent 0.5~5% (eg 0.5%, 3%, 5%)
基质 余量。 Substrate margin.
所述硅酮的分子量为200~10000,为甲基硅油(或乙基硅油或苯基硅油或甲基含氢硅油或甲基苯基硅油)。 The molecular weight of the silicone is 200-10000, which is methyl silicone oil (or ethyl silicone oil or phenyl silicone oil or methyl hydrogen silicone oil or methyl phenyl silicone oil).
所述有机硅抗菌剂是有机硅胍盐(或有机硅季铵盐或氟硅唑)。 The organosilicon antibacterial agent is organosilicon guanidine salt (or organosilicon quaternary ammonium salt or flusilazole).
所述敷料的剂型为气雾剂,其基质由乙醚(或石油醚)与氟利昂(或134a)组成;在基质成分中乙醚(或石油醚)的质量百分比为20~80%,氟利昂(或134a)的质量百分比为20~80%。 The dosage form of the dressing is an aerosol, and its matrix is composed of ether (or petroleum ether) and Freon (or 134a); in the matrix components, the mass percentage of ether (or petroleum ether) is 20-80%, and Freon (or 134a ) The mass percentage is 20~80%.
制备时:将壳聚糖、硅酮与有机硅抗菌剂混合,溶于乙醚或石油醚溶剂中,灌装于铝罐中,再灌入氟利昂或134a,辐照消毒后,即为成品。 During preparation: mix chitosan, silicone and organic silicon antibacterial agent, dissolve in ether or petroleum ether solvent, fill in aluminum cans, then fill in Freon or 134a, and after irradiation disinfection, the finished product is obtained.
产品用于抑制烧伤、外伤、手术、感染引起的增生性疤痕及保护烧伤、外伤、手术、感染引起的各种创面,控制创面感染、保持创面湿润、促进创面愈合。使用时,喷涂于疤痕、创面的表面。 The product is used to inhibit hypertrophic scars caused by burns, trauma, surgery and infection, protect various wounds caused by burns, trauma, surgery and infection, control wound infection, keep wound moist and promote wound healing. When in use, spray on the surface of scars and wounds.
实施例2: Example 2:
敷料的剂型为凝胶剂,其基质成分为聚乙烯醇、羟乙基纤维素、羟甲基纤维素中的2~3个成分混合而成。 The dosage form of the dressing is a gel, and its matrix component is a mixture of 2 to 3 components of polyvinyl alcohol, hydroxyethyl cellulose, and hydroxymethyl cellulose.
制备时: When preparing:
将壳聚糖、硅酮与有机硅抗菌剂混合,混溶于由聚乙烯醇、羟乙基纤维素、羟甲基纤维素中的2~3个成分混合而成的基质中,灌装于塑料管中,辐照消毒后,即为成品。使用时,涂抹于疤痕、创面的表面。 Mix chitosan, silicone and silicone antibacterial agent, dissolve in a matrix made of 2~3 ingredients of polyvinyl alcohol, hydroxyethyl cellulose, and hydroxymethyl cellulose, and fill in In the plastic tube, after irradiation sterilization, it is the finished product. When in use, apply to the surface of scars and wounds.
其余同实施例1。 All the other are with embodiment 1.
实施例3: Example 3:
敷料的剂型为霜剂,其基质成分由下列重量份的成分组成: The dosage form of the dressing is a cream, and its base composition is composed of the following components by weight:
单硬脂酸甘油酯 30~60份(例30份、45份、60份) Glyceryl monostearate 30~60 parts (eg 30 parts, 45 parts, 60 parts)
硬脂酸 80~120份(例80份、100份、120份) Stearic acid 80~120 parts (e.g. 80 parts, 100 parts, 120 parts)
白凡士林 40~60份(例40份、50份、60份) White Vaseline 40~60 parts (eg 40 parts, 50 parts, 60 parts)
液体石蜡 130~180份(例130份、150份、180份) Liquid paraffin 130~180 parts (eg 130 parts, 150 parts, 180 parts)
甘油 80~120份(例80份、100份、120份) Glycerin 80~120 parts (e.g. 80 parts, 100 parts, 120 parts)
吐温-80 120~150份(例120份、135份、150份) Tween-80 120~150 parts (eg 120 parts, 135 parts, 150 parts)
纯化水 350~550份(例350份、450份、550份)。 Purified water 350~550 parts (for example 350 parts, 450 parts, 550 parts).
制备时:将壳聚糖、硅酮与有机硅抗菌剂混合,混溶于由单硬脂酸甘油酯、硬脂酸、白凡士林、液体石蜡、甘油、吐温-80、纯化水而成的基质中,灌装于塑料管中,辐照消毒后,即为成品。使用时,涂抹于疤痕、创面的表面。 During preparation: mix chitosan, silicone and organic silicon antibacterial agent, miscible in glyceryl monostearate, stearic acid, white petrolatum, liquid paraffin, glycerin, Tween-80, purified water In the matrix, filled in plastic tubes, and sterilized by radiation, it is the finished product. When in use, apply to the surface of scars and wounds.
其余同实施例1。 All the other are with embodiment 1.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310128403.XA CN103191460B (en) | 2013-04-15 | 2013-04-15 | Chitosan-silicone dressing as well as preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310128403.XA CN103191460B (en) | 2013-04-15 | 2013-04-15 | Chitosan-silicone dressing as well as preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103191460A CN103191460A (en) | 2013-07-10 |
CN103191460B true CN103191460B (en) | 2014-10-29 |
Family
ID=48714390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310128403.XA Expired - Fee Related CN103191460B (en) | 2013-04-15 | 2013-04-15 | Chitosan-silicone dressing as well as preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103191460B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105250995B (en) * | 2013-09-25 | 2018-06-22 | 河南汇博医疗股份有限公司 | Hyperplastic scar repairs pad pasting and preparation method thereof |
CN103585670A (en) * | 2013-10-17 | 2014-02-19 | 合肥博太医药生物技术发展有限公司 | Plant glucomannan silicone dressing as well as preparation method and application thereof |
CN104288828B (en) * | 2014-10-29 | 2015-10-28 | 东莞市达庆医疗器械有限公司 | A kind of medical bio presses down scar reduce wrinkle dressing and preparation method thereof |
CN104436290B (en) * | 2014-11-07 | 2017-02-08 | 广东泰宝医疗科技股份有限公司 | Functional dressing for inhibiting scar hyperplasia and preparation method thereof |
CN104940222B (en) * | 2015-01-21 | 2018-10-19 | 长沙达瑞奇实业有限公司 | Prevent and treat the preparation method of the creme of hyperplastic scar |
CN106421887A (en) * | 2016-09-30 | 2017-02-22 | 广州赛莱拉干细胞科技股份有限公司 | Medical dressing |
CN107970488A (en) * | 2018-01-08 | 2018-05-01 | 广州润虹医药科技股份有限公司 | A kind of chitin quarternary ammonium salt aquagel antiseptic dressing and preparation method thereof |
CN108403623A (en) * | 2018-05-29 | 2018-08-17 | 南京华开生物科技有限公司 | silicone scar gel |
CN110917380A (en) * | 2019-08-01 | 2020-03-27 | 安徽省小山卫生材料有限公司 | Preparation method of silicone dressing for skin wound |
CN113456877B (en) * | 2021-07-09 | 2023-04-11 | 广西德之然生物科技有限公司 | Organosilicon foam medical dressing and preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1160539A (en) * | 1996-03-28 | 1997-10-01 | 陆达人 | Scar inhibitor and its compounding process |
WO2005081866A2 (en) * | 2004-02-23 | 2005-09-09 | Loma Linda University Medical Center | Hemostatic agent for topical and internal use |
CN101108222A (en) * | 2006-07-17 | 2008-01-23 | 修涞贵 | Method of preparing traditional Chinese medicine unction formulated product for treating cervical erosion, colpitis |
CN102108172A (en) * | 2010-01-20 | 2011-06-29 | 威海世创新材料科技有限公司 | Chitosan/polyvinyl alcohol (PVA) porous composite material and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8951551B2 (en) * | 2005-08-31 | 2015-02-10 | Board Of Regents, The University Of Texas System | Multiribbon nanocellulose as a matrix for wound healing |
GB2461019B (en) * | 2008-04-25 | 2013-06-05 | Medtrade Products Ltd | Haemostatic material |
-
2013
- 2013-04-15 CN CN201310128403.XA patent/CN103191460B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1160539A (en) * | 1996-03-28 | 1997-10-01 | 陆达人 | Scar inhibitor and its compounding process |
WO2005081866A2 (en) * | 2004-02-23 | 2005-09-09 | Loma Linda University Medical Center | Hemostatic agent for topical and internal use |
CN101108222A (en) * | 2006-07-17 | 2008-01-23 | 修涞贵 | Method of preparing traditional Chinese medicine unction formulated product for treating cervical erosion, colpitis |
CN102108172A (en) * | 2010-01-20 | 2011-06-29 | 威海世创新材料科技有限公司 | Chitosan/polyvinyl alcohol (PVA) porous composite material and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
抗菌剂的应用及发展现状;李娜等;《化工技术与开发》;20120531;第41卷(第5期);第30页右栏第3段至第31页右栏第1段 * |
李娜等.抗菌剂的应用及发展现状.《化工技术与开发》.2012,第41卷(第5期),第30-33页. |
Also Published As
Publication number | Publication date |
---|---|
CN103191460A (en) | 2013-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103191460B (en) | Chitosan-silicone dressing as well as preparation method and application thereof | |
CN103127543B (en) | Silicone dressing, and preparation method and use thereof | |
TWI640312B (en) | Antimicrobial compositions and methods of making the same | |
US9044527B2 (en) | Wound care products with peracid compositions | |
CA2882131C (en) | Wound care products with peracid compositions | |
JP5740393B2 (en) | Composition suitable for topical treatment of fungal infections of the skin and nails | |
CN103520767A (en) | Anti-microbial healing-promoting hydrogel dressing and preparation method therefor | |
JP2022552017A (en) | antibacterial organosilane | |
CN105288695B (en) | Adhesive bandage of the ingredient containing graphene oxide and preparation method thereof | |
JP2013532676A5 (en) | ||
CN103143052A (en) | Medical collagen dressing as well as preparation method and use thereof | |
EA022847B1 (en) | Disinfectant and antiseptic formulation having reduced iodine content | |
CN107106726A (en) | Jet printing type burn dressing | |
JP2017514866A5 (en) | ||
CN103127544A (en) | Silver-containing chitosan dressing as well as preparation method and application thereof | |
CN1994477A (en) | Method for preparing medical dressing | |
TWI661829B (en) | Viscous haemostatic compositions and method of treatment | |
CZ302380B6 (en) | Dry substance of hydrogel to cover wounds and process for preparing thereof | |
CN102247374A (en) | Application of tetrahydropyrimidin and derivative thereof in preparation of medicament for treating skin wound | |
CN105709269A (en) | Natural polymer liquid spray for wound protection | |
CN101816677A (en) | Foam type external skin sanitizer and preparation method thereof | |
RU2601897C1 (en) | Agent for treating pyoinflammatory processes in soft tissues and mucous membranes | |
CN106729924A (en) | A kind of medical collagen patch biological dressing and preparation method thereof | |
Yu et al. | Metronidazole and ketoprofen-loaded mesoporous magnesium carbonate for rapid treatment of acute periodontitis in vitro | |
RU2349302C1 (en) | Pharmaceutical composition "oflomelid" for external application in pyoinflammatory disease treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141029 |
|
CF01 | Termination of patent right due to non-payment of annual fee |